Literature DB >> 7699646

Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis.

R M Egan1, R K Munn.   

Abstract

We describe the case of a 25-year-old woman who presented with the antiphospholipid antibody syndrome (APS) manifesting as hemolytic anemia, thrombocytopenia, renal insufficiency, thromboses in multiple sites including skin, spleen and nasal mucosa, and multiple sites of avascular necrosis of bone. Interestingly, she also had low grade disseminated intravascular coagulation, which has been suggested to be a mechanism for avascular necrosis. We suggest that the APS may be one cause of thrombosis in avascular necrosis.

Entities:  

Mesh:

Year:  1994        PMID: 7699646

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?

Authors:  M Y Mok; V T Farewell; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  The repair process of osteonecrosis after a transtrochanteric rotational osteotomy.

Authors:  Takuaki Yamamoto; Satoshi Ikemura; Yukihide Iwamoto; Yoichi Sugioka
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 3.  Orthopedic involvement in antiphospholipid syndrome.

Authors:  Alexander Gorshtein; Yair Levy
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

4.  Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Authors:  Maria Mialdea; Shirish R Sangle; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2009-05-19

Review 5.  High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.

Authors:  Jose A Gómez-Puerta; Pilar Peris; Joan Carles Reverter; Gerard Espinosa; Angeles Martinez-Ferrer; Ana Monegal; Juan Monteagudo; Dolors Tàssies; Nuria Guañabens
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.